98%
921
2 minutes
20
Background: Cardiovascular disease is the leading cause of death in patients with chronic kidney disease. Studies investigating the disproportionate burden of cardiovascular disease have occurred predominantly in the peripheral vasculature, often used noninvasive imaging modalities, and infrequently recruited patients receiving dialysis. This study sought to evaluate invasive coronary dynamic vascular function in patients with end-stage renal failure (ESRF).
Patients And Methods: Patients referred for invasive coronary angiography prior to renal transplantation were invited to participate. Control patients were recruited in parallel. Baseline characteristics were obtained. Coronary diameter (via quantitative coronary angiography) and coronary blood flow (via Doppler Flowire) were measured; macrovascular endothelial-dependent and independent effects were evaluated in response to intracoronary acetylcholine infusion (10 and 10 mol/l) and intracoronary glyceryl trinitrate, respectively. Microvascular function was evaluated by response to adenosine and expressed as coronary flow velocity reserve. Mean values were compared.
Results: Thirty patients were evaluated: 15 patients with ESRF (mean age 52.1 ± 9, male 73%) and 15 control patients (mean age 53.3 ± 13, male 60%). Comorbidity profile, aside from ESRF, was well matched. Baseline coronary blood flow was similar between groups (101.6 ± 10.3 vs. 103.4 ± 9.1 ml/min, P = 0.71), as was endothelial-dependent response to acetylcholine (159.1 ± 16.9 vs. 171.1 ± 16.8 ml/min, P = 0.41). Endothelial-independent response to glyceryl trinitrate was no different between groups (14.3 ± 3.1 vs. 13.1 ± 2.3%, P = 0.73. A significantly reduced coronary flow velocity reserve was observed in the ESRF cohort compared to controls (2.34 ± 0.4 vs. 3.05 ± 0.3, P = 0.003).
Conclusion: Patients with ESRF had preserved endothelial-dependent function however compared to controls, demonstrated significantly attenuated microvascular reserve. An impaired response to adenosine may not only represent a component of the pathophysiological milieu in patients with ESRF but may also provide a basis for the suboptimal diagnostic performance of vasodilatory stress in this population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MCA.0000000000000727 | DOI Listing |
Sci Rep
August 2025
Univ. Grenoble Alpes, INSERM, UA07 STROBE, 2280 rue de la piscine, Saint-Martin d'Hères, 38400, France.
Microbeam Radiation Therapy (MRT) is currently on the verge of entering the clinical phase, necessitating robust quality assurance (QA) with appropriate dosimeters to ensure patient safety. However, MRT dosimetry presents significant challenges due to its intrinsic characteristics, including steep dose gradients with alternating high and low dose regions-referred to as peaks and valleys (valley doses comprising only 5-7% of peak doses)-micrometric resolution requirements, the use of low-to-medium energy X-rays and extremely high dose rates of up to 16 kGy/s. Currently, Gafchromic films are considered the gold standard for patient QA.
View Article and Find Full Text PDFSkin Appendage Disord
April 2025
Internal Medicine Department, Faculty of Medicine (Girls), Al-Azhar University, Cairo, Egypt.
Introduction: Chronic renal failure can impact various body systems, including the skin and its appendages. Patients with uremic conditions have been observed to experience a variety of nail changes. This study was conducted to evaluate the presence and type of fingernail changes in patients with end-stage renal failure (ESRF) on regular hemodialysis (HD) by nail dermoscopy.
View Article and Find Full Text PDFBrain Sci
March 2025
Department of Neurosurgery, University Hospital of Larissa, School of Medicine, University of Thessaly, 41500 Larissa, Greece.
: End-stage renal failure (ESRF) patients are at an increased risk of various neurological complications, particularly after hemodialysis. The current case report describes a rare presentation of spontaneous intracranial hypotension (SIH) in a patient with ESRF caused by systemic lupus erythematosus (SLE). We present our case report.
View Article and Find Full Text PDFPharmacoecon Open
July 2025
Geriatric Education & Research Institute, Singapore, Singapore.
Background: Patients with nonmalignant end-stage organ diseases often incur healthcare costs in the last year of life that are disproportionately higher than in the period prior. Studies on healthcare expenditure (HCE) trends in these patients have largely focused on the final year of life, and examining a longer-term trajectory could better support healthcare professionals to target the timing and methods of care management. In this study, we aim to describe the HCE trajectories of end-stage organ disease (ESOD) over the last 5 years of life, compared against advanced cancer (AC).
View Article and Find Full Text PDFANZ J Surg
April 2025
Department of Vascular, Endovascular and Transplant Surgery, Christchurch Hospital, Christchurch, New Zealand.
Background: Over the last decade, there has been a steady increase in the number of patients diagnosed with end stage renal failure (ESRF). Renal transplant remains the best available treatment for ESRF. The aim of this study is to assess the surgical outcomes following renal transplantation in a single tertiary centre in Aotearoa New Zealand.
View Article and Find Full Text PDF